| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Christian Gluud | Q26265142 |
| Janus C Jakobsen | Q41279147 | ||
| P2093 | author name string | Joshua Feinberg | |
| Naqash J Sethi | |||
| Sanam Safi | |||
| Emil E Nielsen | |||
| P2860 | cites work | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Q21195843 |
| Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews | Q24185986 | ||
| Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation | Q24187110 | ||
| Industry sponsorship and research outcome | Q24202591 | ||
| Pharmacological cardioversion for atrial fibrillation and flutter | Q24246997 | ||
| Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods | Q24288962 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation | Q57312493 | ||
| 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: | Q57627013 | ||
| Atrial fibrillation | Q58645594 | ||
| Incidence and predictors of atrial flutter in the general population | Q61670401 | ||
| Surgery for cardiac arrhythmias | Q64764814 | ||
| Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. | Q64895943 | ||
| The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology | Q67700855 | ||
| Effect of an irregular ventricular rhythm on cardiac output | Q71907197 | ||
| Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks | Q73566765 | ||
| Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators | Q73594702 | ||
| International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use | Q74795924 | ||
| Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks | Q82918082 | ||
| Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation | Q83178529 | ||
| Increased mortality among patients taking digoxin--analysis from the AFFIRM study | Q85551923 | ||
| 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society | Q86275165 | ||
| Surgery for Atrial Fibrillation | Q87444747 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management | Q28268244 | ||
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society | Q29614693 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | Q29615706 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology | Q29619792 | ||
| Meta-analyses involving cross-over trials: methodological issues | Q29620304 | ||
| Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins | Q29620720 | ||
| Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis | Q30245592 | ||
| Surgical ablation of atrial fibrillation during mitral-valve surgery. | Q30366105 | ||
| Digoxin in patients with permanent atrial fibrillation: data from the RACE II study | Q30830811 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| Estimating required information size by quantifying diversity in random-effects model meta-analyses. | Q33521365 | ||
| Evidence at a glance: error matrix approach for overviewing available evidence | Q33710053 | ||
| The evidence regarding the drugs used for ventricular rate control. | Q33839797 | ||
| A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey | Q34105149 | ||
| Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study | Q34117950 | ||
| False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review | Q38926363 | ||
| Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis | Q39432033 | ||
| Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study | Q39497957 | ||
| Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals | Q39834471 | ||
| Current concepts in radiotherapy and their impact on oncology | Q40163039 | ||
| Rate-control treatment and mortality in atrial fibrillation | Q40525520 | ||
| A comparison of 50-J versus 100-J shocks for direct-current cardioversion of atrial flutter | Q40823066 | ||
| Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies | Q41416463 | ||
| Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial | Q42137115 | ||
| Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial | Q42679144 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42874726 | ||
| Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
| Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter | Q43787981 | ||
| Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials | Q45139213 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. | Q45999295 | ||
| Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure. | Q46095564 | ||
| Atrioventricular Junction Ablation for Atrial Fibrillation | Q51450107 | ||
| The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation | Q51693714 | ||
| Methods for combining randomized clinical trials: strengths and limitations | Q52599212 | ||
| Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation | Q53569088 | ||
| A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. | Q55036185 | ||
| 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q56986288 | ||
| Apixaban in Patients with Atrial Fibrillation | Q34163710 | ||
| A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs | Q34248170 | ||
| Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the N | Q34317125 | ||
| Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction | Q34415281 | ||
| Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review | Q34422492 | ||
| Catheter ablation of atrial flutter and macroreentrant atrial tachycardia | Q34493604 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | Q34527664 | ||
| 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. | Q34538645 | ||
| Inflammation as a risk factor for atrial fibrillation | Q34543274 | ||
| Amiodarone versus sotalol for atrial fibrillation | Q34557369 | ||
| Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. | Q34588710 | ||
| Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
| Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation | Q34723534 | ||
| Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 | ||
| Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment | Q35177830 | ||
| Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK | Q35582163 | ||
| Effectiveness and safety of warfarin and anti-platelet drugs for the primary prevention of stroke in patients with non-valvular atrial fibrillation: a meta-analysis. | Q35756360 | ||
| Monophasic and biphasic shock for transthoracic conversion of atrial fibrillation: Systematic review and network meta-analysis | Q35896357 | ||
| Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations | Q36065277 | ||
| Bias in clinical intervention research. | Q36380552 | ||
| Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study | Q36421870 | ||
| Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial | Q36860117 | ||
| Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses | Q37138228 | ||
| Therapeutic considerations in applying rate control therapy for atrial fibrillation | Q37204953 | ||
| Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation | Q37993754 | ||
| Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials | Q38013391 | ||
| Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis | Q38043541 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies | Q38044510 | ||
| Atrial fibrillation: antiarrhythmic therapy | Q38252410 | ||
| What is 'valvular' atrial fibrillation? A reappraisal | Q38255269 | ||
| How to define valvular atrial fibrillation? | Q38549124 | ||
| Systematic Reviews of Anesthesiologic Interventions Reported as Statistically Significant: Problems with Power, Precision, and Type 1 Error Protection | Q38637092 | ||
| The Epidemiology of Atrial Fibrillation and Stroke. | Q38826745 | ||
| P433 | issue | 1 | |
| P921 | main subject | atrial fibrillation | Q815819 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 47 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Systematic Reviews | Q18216009 |
| P1476 | title | The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis | |
| P478 | volume | 6 |
| Q89662459 | Health apps targeting children with overweight-a protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials |
| Q44824832 | The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis |
Search more.